We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Generic Line
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Generic Line
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Sandoz Launches Zarxio, Sets Price At 15 Percent Below Neupogen
Price:
$40.00
Learn More
Pfizer Acquires Marketing Rights to Potential Copaxone Generic
Price:
$40.00
Learn More
Teva Recalls Amphetamine Tablets Due to Impurities
Price:
$40.00
Learn More
Hetero Launches Biosimilar of Roche’s Rituxan in India
Price:
$40.00
Learn More
ICH Recommends Limited Use of Pharmaceutical Solvent
Price:
$40.00
Learn More
India Cancels EU Trade Talks Over GVK-Tested Drugs Ban
Price:
$40.00
Learn More
Upsher-Smith’s Namenda ANDA Wins FDA Approval
Price:
$40.00
Learn More
Court Rejects AstraZeneca’s Bid to Block Mylan’s Generic Nexium
Price:
$40.00
Learn More
FDA Sets New Dissolution Specifications for IR Drugs
Price:
$40.00
Learn More
Allergan is Latest Focus of Generics Pricing Probe
Price:
$40.00
Learn More
House Panel Slams FDA Handling of Cybersecurity Breach
Price:
$40.00
Learn More
AbbVie Steps Up Attack on FDA’s Biosimilars Labeling Approach
Price:
$40.00
Learn More
Previous
1
2
3
4
5
6
7
8
9
10
11
12
…
21
22
Next